High Worldwide Demand of Insulin Patch Pumps in Covid19 Pandemic
The global insulin patch pumps market size is expected to reach USD 1.7 Billion by 2027, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 10.9% over the forecast period. The market is primarily driven by factors such as increasing diabetic population and rising awareness about advanced diabetes management solutions. Moreover, technological advancements and several product launches in the field of insulin patch pumps are further augmenting growth.
Patch pumps are easy to use and more
convenient than conventional insulin pumps. In addition, they are more
affordable than conventional insulin pumps and are rapidly capturing a
significant share of the insulin patch pumps market. Key players are using
novel technologies and offer user-friendly insulin delivery solutions at lower
prices. This is expected to increase the frequency of product launches during
the forecast period, boosting overall growth.
Increasing healthcare expenditure related
to diabetes and rising number of FDA approvals are further aiding growth. For
instance, in March 2019, a South Korean Company-EoFlow-received FDA approval
for its newly designed patch pump-EoPatch in the U.S.
Browse Full Report with TOC and Free Sample
Copy@ https://www.grandviewresearch.com/industry-analysis/insulin-patch-pump-market
Regional Insights
Regionally, the market is segmented into North America, Latin
America, Europe, Asia Pacific, and Middle East & Africa. North America
dominated the market owing to availability of major brands of insulin patch
pumps. Moreover, increasing healthcare expenditure and rising frequency of FDA
approvals is also aiding growth in the region. For instance, in 2019, South
Korean Company EoFlow received FDA approval for its newly designed patch
pump-EOPatch-in the U.S.
Asia Pacific is expected to grow at the fastest pace due to
factors such as rapidly growing diabetic population and increasing awareness
about advanced digital diabetes
management solutions in the region. In addition, increasing product
launches and technological advancements in the field of insulin patch pumps are
expected to aid regional growth.
Key Companies & Market
Share Insights
Some of the leading players are Roche Diagnostics;
Medtronic Plc; Valeritus; Insulet Corporation; Cellnovo Ltd; and CeQur. The
major players are focusing on mergers & acquisitions, technological
collaborations, and innovative product launches. For instance, in July 2018,
Cequr purchased a certain asset from Calibra Medical-a subsidiary of Johnson
& Johnson. These assets include latter’s wearable insulin delivery
technology.
Contact
Us:
Grand View Research, Inc.
201 Spear Street 1100,
San Francisco, CA 94105
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment